Table 2.
Pre-intervention | Post-intervention | |||
---|---|---|---|---|
Diagnosis | Patients (n=435) | Risk for DDIs (%) | Patients (n=445) | Risk for DDIs (%) |
HTN | 149 | 99 (66) | 111 | 60 (54) |
COPD * | 72 | 52 (72) | 93 | 48 (52) |
CVA | 56 | 37 (66) | 44 | 27 (61) |
DM | 48 | 29 (60) | 34 | 28 (82) |
IHD | 25 | 19 (76) | 32 | 24 (75) |
TB | 21 | 17 (81) | 21 | 13 (62) |
BPH | 24 | 15 (63) | 21 | 11 (52) |
AF | 14 | 14 (100) | 19 | 13 (68) |
MI | 6 | 5 (83) | 7 | 7 (100) |
CCF | 8 | 7 (88) | 3 | 3 (100) |
ALD | 17 | 7 (41) | 15 | 7 (47) |
RI | 12 | 7 (58) | 15 | 9 (60) |
RHD | 13 | 7 (54) | 6 | 3 (50) |
CRF | 18 | 6 (33) | 22 | 6 (27) |
Cancer | 12 | 5 (42) | 5 | 1 (20) |
ESRD | 8 | 5 (63) | 1 | 1 (100) |
Parkinsonism | 7 | 4 (57) | 1 | 1 (100) |
Miscellaneous | 125 | 56 (45) | 285 | 96 (34) |
chi-square= 7.22, p= 0.007 decrease in the incidence after intervention
HTN: hypertension, COPD: chronic obstructive pulmonary diseases, CVA: cerebrovascular accident, DM: diabetes mellitus, IHD: ischemic heart disease, TB: tuberculosis, BPH: benign prostatic hyperplasia, AF: atrial fibrillation, MI: myocardial farction, CCF: congestive cardiac failure, ALD: alcoholic liver diseases, RI: renal impairment, RHD: rheumatic heart disease, CRF: chronic renal failure, ESRD: end stage renal disease.